# Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

> **NCT04770285** · NA · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 386 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** CT-152 - Digital Therapeutic
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT04770285
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-25
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-10-26
- **Target enrollment:** 386 (ACTUAL)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770285, "Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04770285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*